Nova Scotia, Canada Clinical Trials

A listing of Nova Scotia, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 275 clinical trials
featured
Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease

The active Neuro RX Gamma device uses non-invasive near-infrared energy delivered to the brain transcranially and intranasally with the intention to improve cognitive functioning and quality of life in patients with moderate to severe Alzheimer's Disease. Treatment will occur at home-based treatment sessions with the device.A potential participant will undergo …

mini-mental state examination
mental state examination
stroke
True North Clinical Research
 (4.1 away) Contact site
  • 0 views
  • 30 Jul, 2021
  • +8 other locations
featured
C3711005  

The study will evaluate the effect of coadministration of a range of doses of DGAT2i with 1 dose of ACCi, on hepatic steatosis and the ability of DGAT2i to mitigate ACCi-induced elevations in serum triglycerides. The study has a 2-part design with sequential conduct of Part 1 and Part 2 …

Nova Scotia Health Authority QE II Health Sciences Centre
 (8.6 away)
  • 25 views
  • 03 Aug, 2021
  • +10 other locations
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease

Individuals receiving dialysis are at risk of heart failure and heart related death. There is an urgent need for treatments that reduce the risk of these problems in patients that require dialysis. Spironolactone is a pill used to prevent heart failure and related deaths in patients that do not require …

Queen Elizabeth II Health Science Centre
 (8.5 away) Contact site
  • 41 views
  • 26 Jan, 2021
  • +97 other locations
Efficacy and Safety of Etripamil for the Termination of Spontaneous PSVT. NODE 301 [Part 1 and Part 2 (The RAPID Study)]

This is a two-part, multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of etripamil NS self-administered by patients who experience an episode of paroxysmal ventricular tachycardia (PSVT) in an at-home setting. Part 1 comprised the conduct of the NODE-301 study up to the date of the adjudication …

Dalhousie University - QEII Health Sciences Centre, Nova Scotia Health Authority-Halifax Infirmary
 (8.1 away) Contact site
  • 281 views
  • 05 May, 2021
  • +127 other locations
A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCL

This study is evaluating the efficacy of acalabrutinib in combination with bendamustine and rituximab (BR) compared with placebo plus BR in subjects with previously untreated mantle cell lymphoma.

bendamustine
cyclin d1
acalabrutinib
rituximab
Research Site
 (8.6 away) Contact site
  • 1270 views
  • 24 Jul, 2021
  • +250 other locations
Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC

Sometimes, cancer patients receive an initial treatment, followed by additional treatment to lower the chance of cancer coming back. The standard or usual treatment for this type of disease is initially having radiation therapy at the same time as chemotherapy (with a drug called cisplatin), with no additional therapy afterwards

x-rays
oropharyngeal carcinoma
carcinoma
neutrophil count
treatment schedule
QEII Health Sciences Centre
 (8.5 away) Contact site
  • 56 views
  • 24 Jul, 2021
  • +29 other locations
Hydroxychloroquine in Individuals At-risk for Type 1 Diabetes Mellitus

The study is a 2-arm, double blinded, multicenter, 2:1 randomized, placebo controlled clinical trial. Subjects will receive hydroxychloroquine or placebo and close monitoring for progression of T1D.

IWK Health Center
 (7.2 away) Contact site
  • 190 views
  • 04 Aug, 2021
  • +48 other locations
Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy

Psoriasis (PsO) is a chronic disease characterized by marked inflammation of the skin that results in thick, red, scaly plaques. This study will assess how safe and effective risankizumab is compared to apremilast in adult participants with moderate plaque psoriasis. Adverse events and change in disease symptoms will be monitored. …

plaque psoriasis
systemic therapy
arthritis
risankizumab
apremilast
Eastern Canada Cutaneous Resea /ID# 230120
 (8.2 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +61 other locations
An Efficacy and Safety Study of ALZ-801 in APOE4/4 Early AD Subjects

This study is being conducted to evaluate the safety and efficacy of ALZ-801 in Early Alzheimer's disease (AD) subjects with the APOE4/4 genotype. This is a double-blind, randomized trial with one dose of ALZ-801 compared to placebo.

True North Clinical Research
 (4.0 away) Contact site
  • 0 views
  • 24 Jul, 2021
  • +67 other locations
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)

This study is done to find out whether the medicine, semaglutide, has a positive effect on early Alzheimer's disease. Participants will either get semaglutide or placebo (a "dummy" medicine which does not contain any study medicine) - which treatment participants get is decided by an equal chance. The study will …

Novo Nordisk Investigational Site
 (8.6 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +149 other locations